ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 132 filers reported holding ALLAKOS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,077 | -47.9% | 35,276 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $153,803 | +25.1% | 35,276 | +180.9% | 0.00% | 0.0% |
| Q4 2021 | $122,943 | -90.8% | 12,558 | 0.0% | 0.00% | -91.7% |
| Q3 2021 | $1,329,515 | +24.0% | 12,558 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $1,072,076 | -11.5% | 12,558 | +18.9% | 0.01% | -9.1% |
| Q1 2021 | $1,211,962 | -18.0% | 10,559 | 0.0% | 0.01% | -26.7% |
| Q4 2020 | $1,478,260 | +67.4% | 10,559 | -2.6% | 0.02% | +50.0% |
| Q3 2020 | $882,837 | +13.3% | 10,839 | 0.0% | 0.01% | +11.1% |
| Q2 2020 | $778,891 | +112.8% | 10,839 | +31.8% | 0.01% | +80.0% |
| Q1 2020 | $365,975 | -53.3% | 8,226 | 0.0% | 0.01% | -37.5% |
| Q4 2019 | $784,431 | +21.3% | 8,226 | 0.0% | 0.01% | +14.3% |
| Q3 2019 | $646,810 | +81.5% | 8,226 | 0.0% | 0.01% | +75.0% |
| Q2 2019 | $356,431 | +29.1% | 8,226 | +20.7% | 0.00% | +33.3% |
| Q1 2019 | $276,129 | +30.7% | 6,818 | +68.7% | 0.00% | 0.0% |
| Q4 2018 | $211,275 | -23.8% | 4,042 | -34.4% | 0.00% | 0.0% |
| Q3 2018 | $277,093 | – | 6,159 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 2,268,188 | $184,744,000 | 7.82% |
| Fairmount Funds Management LLC | 164,662 | $13,412,000 | 5.68% |
| Samsara BioCapital, LLC | 192,334 | $15,666,000 | 4.37% |
| Redmile Group, LLC | 2,425,560 | $197,562,000 | 3.63% |
| Boxer Capital, LLC | 675,000 | $54,979,000 | 1.90% |
| Rock Springs Capital Management LP | 241,582 | $19,677,000 | 0.50% |
| Handelsinvest Investeringsforvaltning | 30,000 | $2,444,000 | 0.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $1,279,000 | 0.41% |
| Eventide Asset Management | 160,000 | $13,032,000 | 0.26% |
| Cormorant Asset Management, LP | 75,000 | $6,109,000 | 0.24% |